The classification of bacterial survival strategies in the presence of antimicrobials

Microb Pathog. 2021 Jun:155:104901. doi: 10.1016/j.micpath.2021.104901. Epub 2021 Apr 27.

Abstract

The survival of bacteria under antibiotic therapy varies in nature and is based on the bacterial ability to employ a wide range of fundamentally different resistance mechanisms. This great diversity requires a disambiguation of the term 'resistance' and the development of a more precise classification of bacterial survival strategies during contact with antibiotics. The absence of a unified definition for the terms 'resistance', 'tolerance' and 'persistence' further aggravates the imperfections of the current classification system. This review suggests a number of original classification criteria that will take into account (1) the bacterial ability to replicate in the presence of antimicrobial agents, (2) existing evolutionary stability of a trait within a species, and (3) the presence or absence of specialized genes that determine the ability of a microorganism to decrease its own metabolism or switch it completely off. This review describes potential advantages of the suggested classification system, which include a better understanding of the relationship between bacterial survival in the presence of antibiotics and molecular mechanisms of cellular metabolism suppression, the opportunity to pinpoint targets to identify a true bacterial resistance profile. The true resistance profile in turn, could be used to develop effective diagnostic and antimicrobial therapy methods, while taking into consideration specific bacterial survival mechanisms.

Keywords: Bacteria with reduced or halted metabolism; Dormancy; Persister cells; Resistance; Survival strategies; Tolerance; VBNC; Viable but nonculturable bacteria.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bacteria* / genetics
  • Bacterial Infections* / drug therapy
  • Drug Resistance, Bacterial
  • Humans
  • Phenotype

Substances

  • Anti-Bacterial Agents